CA
NZ
UK
AU
IND
US
Biotech stocks made headlines on Thursday, September 25, 2025, with standout performances driven by unique company developments and promising clinical progress. Despite a challenging market environment, PepGen Inc., HeartSciences Inc., and Jasper Therapeutics delivered remarkable gains, fueled by innovation, strategic pivots, and investor optimism. …
Lloyds Banking Group PLC (NYSE:LYG) has been given a consensus rating of "Moderate Buy" by seven brokerages currently covering the stock, according to MarketBeat. Of the analysts, two rated the stock ashold, four provided abuyrecommendation, and one assigned astrong buy.
Image Source: ShutterstockLong-Term Price Dynamics and BreakoutAn analysis of the monthly chart for silver reveals a significant development. For years, the price of silver consolidated within a broad symmetrical wedge pattern that began after the peak in 2011. Recently, the price has broken out …
Index Update:Investors stayed cautious ahead of key economic data and Fed commentary, with focus on the potential for another rate cut next month. Intel gained nearly 4% premarket on reports it approached Apple for an investment, lifting Apple shares slightly. Lithium Americas surged 13% …
Evaxion A/S (NASDAQ:EVAX), a clinical-stage TechBio company focused on AI-Immunology™ powered vaccines, announced that MSD (Merck & Co., Inc.) has exercised its option to license the vaccine candidate EVX-B3. As part of the agreement, Evaxion receives a $7.5 million cash payment and is eligible …
SciSparc Ltd. (Nasdaq:SPRC), a clinical-stage pharmaceutical company specialising in therapies for central nervous system disorders, announced that its board of directors has resolved to initiate a new program to advance 3D protein modeling using quantum computing technology. The Initiative seeks to enhance drug discovery …
JPMorgan Chase & Co. increased its target price for Roivant Sciences Ltd. (NASDAQ:ROIV) from USD 16.00 to USD 20.00 in a research note issued on Thursday, according to Benzinga. The brokerage maintained an “overweight” rating, citing potential upside of 32.98% based on the stock’s …
Taiwan Semiconductor’s mastery of advanced packaging has turned CoWoS into the most strategic chokepoint of the digital age.
Despite a broad pullback in the U.S. stock market on September 24, 2025, a handful ofNASDAQnames broke away from the downward tide. Biotech innovator UniQure (QURE), clinical-stage developer Cidara Therapeutics (CDTX), and digital real estate disruptor Opendoor Technologies (OPEN) each delivered standout gains, fueled …
U.S. stock sentiment improved on renewed AI optimism, with Alibaba surging nearly 9% premarket after announcing increased AI investment, while Micron rose over 1% on strong earnings and outlook. Nvidia and Broadcom also traded higher, though investors remained cautious as Fed Chair Powell highlighted …
Please wait processing your request...